CHRISTINA KEY: Open Payments
NPI 1104247378 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 23 payments from 15 companies in 2025. Trend: 2023 $741 · 2024 $394 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $79 |
| PFIZER INC. | 4 | $71 |
| ABBVIE INC. | 2 | $33 |
| Novo Nordisk Inc | 2 | $33 |
| Eisai Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: PREVNAR 20, MOUNJARO, Ozempic, Leqembi, Kerendia, REXULTI, ZEPBOUND, Sunosi.
Industry payments across OK — which companies pay providers there.
